• Early Bladder Cancer Detection Just the Beginning for This At-Home Urine Test

    Mar 18 | Diagnostics World | The incidence of bladder cancer is rising significantly due to population aging and, while survival rates are relatively high, when diagnosed late patients may need to undergo bladder removal regardless of survival. Early detection and treatment of bladder cancer are therefore crucial to preserving the organ and maintaining the patient’s quality of life. More

  • Venture Capital Steps in Amid Government Funding Uncertainty

    Mar 13 | Diagnostics World | Altitude Lab, a nonprofit established by biotech company Recursion, has launched a pre-seed venture fund aimed at supporting 10 to 15 early-stage startups navigating the current uncertainty surrounding government funding. Executive Director Chandana Haque hopes other private investment groups will follow suit to bridge the gap left by disrupted Small Business Innovation Research (SBIR) grants, which have historically been crucial in launching startups and securing follow-on investments. More

  • Platelet Function Test Could Help Doctors and Scientists Tackle Heart Disease

    Mar 11 | Diagnostics World | A new platelet function test has been developed by researchers in the UK that could help pharmaceutical companies design better, safer drugs for the prevention of heart attacks and strokes and, longer term, to help doctors know which of their high-risk patients should be put on blood thinners. Ultimately, the test could be developed into a point-of-care preventive diagnostic for the general population that’s as simple to use as a blood glucose fingerprick test. More

  • Personalis ctDNA Test Paves Way for Medicare Reimbursement in Breast Cancer

    Mar 06 | Diagnostics World | A retrospective study from Personalis for its NeXT Personal test, an ultra-sensitive circulating tumor DNA (ctDNA) test for cancer patients and survivors, has been published in Annals of Oncology. The study was conducted with researchers from The Institute of Cancer Research, London and The Royal Marsden NHS Foundation Trust in the UK. More

  • Methylation Monitoring Predicts Pan-Cancer Outcomes

    Mar 05 | Diagnostics World | In a paper published last month in Nature Scientific Reports, authors validate Northstar Response, BillionToOne's novel tissue-free circulating tumor DNA (ctDNA) liquid biopsy test that enables physicians to monitor cancer treatment response in Stage III-IV cancers with a blood draw. More

  • Pan-European Genomic Reanalysis Project Turns Up Over 500 Diagnoses

    Mar 04 | Diagnostics World | A transcontinental collaborative effort brought together 300 experts from 12 European countries and Canada to try and crack the genetic cause of thousands of unsolved rare disease cases. Through data-sharing and genetic reanalysis, this “coalition of the willing” has most recently succeeded in providing more than 500 patients with a long-awaited diagnosis—and peace of mind to unaffected family members about whether they carry the risk variant. More

  • Dovetail’s Platform for Oncology Research, Novel iPSC Foundry, More

    Feb 27 | Diagnostics World | Dovetail Genomics announced its early access services for FFPE (Formalin-Fixed Paraffin-Embedded) sample analysis; Cellino announced its collaboration with Mass General Brigham’s Gene and Cell Therapy Institute (GCTI) to launch the world’s first hospital-based autologous induced pluripotent stem cell (iPSC) Foundry; and more. More

  • Follow the Money: Radionuclide Therapies, GIP Antagonists for Obesity, More

    Feb 26 | Diagnostics World | A transcontinental collaborative effort brought together 300 experts from 12 European countries and Canada to try and crack the genetic cause of thousands of unsolved rare disease cases. Through data-sharing and genetic reanalysis, this “coalition of the willing” has most recently succeeded in providing more than 500 patients with a long-awaited diagnosis—and peace of mind to unaffected family members about whether they carry the risk variant. More

  • University of Cambridge Develops ‘Sleep Pajamas’ For Monitoring Sleep Disorders

    Feb 20 | Diagnostics World | Researchers at the University of Cambridge have developed washable and comfortable ‘smart pajamas’ to help monitor sleep disorders at home. The pajamas negate the need for sticky patches, monitoring equipment, or visiting sleep clinics for specialty tests. More

  • LinusBio Launches ClearStrand-ASD That Detects Autism With a Single Hair Strand

    Feb 13 | Diagnostics World | Amid an industrywide shortage of workers and hospital capacity, a multimodal artificial intelligence (AI) platform providing real-time visibility into the clinical picture for patients is finding a national audience with health systems big and small who want to “make the right thing the easy thing to do” for their overburdened clinicians. More
View more articles

 
DXX-Industry-spotlight

merck


Custom Diagnostic Antibody Development & Manufacturing Services

Overcome Process Challenges by outsourcing your custom antibody production to us. How partnering with an antibody production expert can improve your assay, accelerate launch, and maintain your manufacturing.

Learn more